Conference Coverage
Conference Coverage
Defining wellness in IBD
Psychobehavioral researcher says it goes beyond just symptom management and quality of life measures.
Conference Coverage
NAFLD linked to worse outcomes in IBD
New nationwide analysis suggests involvement of nonmetabolic factors.
Conference Coverage
Racial, social inequities persist in IBD
Three in four patients are White, but there is growing appreciation of the diversity of the population and the need for equity in care.
Conference Coverage
COVID-19 risks linked to medications in IBD
Some drugs may lead to worse outcomes, though infection rates appear similar.
Conference Coverage
Liver injury linked to COVID-19–related coagulopathy
Cells that line the liver's blood vessels produce high levels of factor VIII, a coagulation factor, when they are exposed to interleukin-6, an...
Conference Coverage
Partnering with dietitians can bridge gaps in IBD care
Dr. Ashwin N. Ananthakrishnan said it’s key for gastroenterologists to communicate what exactly they want the dietitian to address and not merely...
Conference Coverage
GI physicians urge COVID-19 vaccines for all IBD patients
"The [vaccines] leading the pack do not have any replicating virus and thus can be used in immunocompromised people," said Maria Abreu, MD.
Conference Coverage
IBD: Fecal calprotectin’s role in guiding treatment debated
"There's a lot of variation, which makes the cutoffs good on average for populations but a little bit more difficult to apply to individuals,"...
Conference Coverage
Obesity phenotyping matches patients with more effective interventions
A prospective, randomized study suggests obesity phenotyping can guide selection of more effective, tailored weight-loss drug regimens.
Conference Coverage
Rapid relief of opioid-induced constipation with MNTX
Subcutaneously administered, peripherally acting mu-opioid receptor antagonist, relieves opioid-induced constipation in both chronic, noncancer-...